Lipid profile and HDL-associated paroxonase in children with celiac disease. Impact of gluten free diet
; Bottero, Adriana ; Neder, Daniela ; Martin, Maximiliano Emanuel
; Botta, Eliana Elizabeth
; Ferraro, Maria Florencia
; Lozano Chiappe, Ezequiel Silvano
; Brites, Fernando Daniel
; Boero, Laura Estela Otros responsables
Fecha
2020
Editorial
Fundación Revista Medicina
Revista
TĆtulo del libro
Nombre del evento
LXIV Reunión Anual de la Sociedad Argentina de Investigación ClĆnica; LI Reunión Anual de la Asociación Argentina de FarmacologĆa Experimenta; XXI Reunión Anual de la Sociedad Argentina de BiologĆa; XXXI Reunión Anual de la Sociedad Argentina de ProtozoologĆa; IX Reunión Anual de la Asociación Argentina de Nanomedicinas; VI Reunión CientĆfica Regional de la Asociación Argentina de Ciencia y TecnologĆa de Animales de Laboratorio
Fecha del evento
2019-11-13
Institución organizadora
Sociedad Argentina de Investigación ClĆnica
Asociación Argentina de FarmacologĆa Experimental
Sociedad Argentina de BiologĆa
Sociedad Argentina de ProtozoologĆa
Asociación Argentina de Nanomedicinas
Asociación Argentina de Ciencia y TecnologĆa de Animales de Laboratorio
Asociación Argentina de FarmacologĆa Experimental
Sociedad Argentina de BiologĆa
Sociedad Argentina de ProtozoologĆa
Asociación Argentina de Nanomedicinas
Asociación Argentina de Ciencia y TecnologĆa de Animales de Laboratorio
ISSN
1669-9106
eISSN
ISBN
Idioma
InglƩs
Tipo del evento
Reunión
Clasificación temÔtica
Palabras clave
Resumen
There is growing evidence, both in adults and children, that celiac disease (CD) could be associated with non-identified atherogenic risk factors and, consequently, with cardiovascular disease. In this context, high density lipoproteins (HDL) constitute the only antiatherogenic fraction, being the inhibition of low density lipoprotein (LDL) oxidation one of its main functions. This capacity depends on several HDL-associated components, such as the antioxidant enzyme paraoxonase (PON1). Our objectives were: 1) To assess the relationship between CD and the presence of atherogenic risk factors in recently diagnosed children compared to healthy controls, and 2) the effect of gluten-free diet (GFD). The study included 22 CD children and 22 controls. Eleven CD children completed 6 months of GFD. Triglycerides (TG), total cholesterol (TC), HDL-C, LDL-C, apolipoproteins A-I and B, glucose, haematological parameters, high sensitive C reactive protein (hsCRP), folic acid and vitamin B12 were measured by standardized methods. PON1 activity was evaluated employing two substrates: paraoxon (PON activity) and phenylacetate (ARE activity). There were significant differences in age between CD children and controls, so statistical analyses were performed adjusting by age. The CD children showed lower HDL-C, plasma iron, tranferrin saturation, folic acid and ARE activity (p<0.05) compared to controls. Regarding the longitudinal analysis, both HDL-C and PON1 activity increased while TG decreased after 6 months of GFD (p<0.05). Interestingly, after treatment HDL-C achieved by CD children resulted to be similar to the levels observed in control subjects. Conclusions: Children showed a more atherogenic lipid profile and lower ARE activity compared to healthy controls. These alterations were partially reversed after GFD, indicating a potentially beneficial effect of this treatment on both traditional risk factors and markers of HDL quality and functionality.
Colecciones
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este Ćtem se describe como by-nc-sa
